Nicholas P van der Meulen (Nicholas P Van der Meulen, N P van der Meulen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Molecules (Basel, Switzerland)

Pharmaceutics

Cancers

Journal of labelled compounds & radiopharmaceuticals

Paul Scherrer Institut

Stellenbosch University Faculty of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Paul Scherrer Institut Jul 01 2013

Switzerland

Group Leader: Radionuclide Development :: Laboratory of Radiochemistry

Education History

Stellenbosch University Faculty of Science May 01 2004 - Feb 01 2008

South Africa

PHD

Publications

Frederic Juget, Teresa Durán, Youcef Nedjadi, Zeynep Talip, Pascal V Grundler, Chiara Favaretto, Pierluigi Casolaro, Gaia Dellepiane, Saverio Braccini, Claude Bailat, Nicholas P van der Meulen
Activity Measurement of 44 Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics. Molecules (Basel, Switzerland) 28 (3) (2023)
Barbara Happl, Marie R Brandt, Theresa Balber, Katarína Benčurová, Zeynep Talip, Alexander Voegele, Petra Heffeter, Wolfgang Kandioller, Nicholas P van der Meulen, Markus Mitterhauser, Marcus Hacker, Bernhard K Keppler, Thomas L Mindt
Synthesis and Preclinical Evaluation of Radiolabeled [ 103 Ru]BOLD-100. Pharmaceutics 15 (11) (2023)
Frederic Juget, Teresa Durán, Youcef Nedjadi, Zeynep Talip, Pascal V Grundler, Chiara Favaretto, Pierluigi Casolaro, Gaia Dellepiane, Saverio Braccini, Claude Bailat, Nicholas P van der Meulen
Activity Measurement of 44 Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics. Molecules (Basel, Switzerland) 28 (3) (2023)
Marianna Tosato, Marco Verona, Chiara Favaretto, Marco Pometti, Giordano Zanoni, Fabrizio Scopelliti, Francesco Paolo Cammarata, Luca Morselli, Zeynep Talip, Nicholas P van der Meulen, Valerio Di Marco, Mattia Asti
Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation. Molecules (Basel, Switzerland) 27 (13) (2022)
Thiago Viana Miranda Lima, Silvano Gnesin, Klaus Strobel, Maria Del Sol Pérez, Justus E Roos, Cristina Müller, Nicholas P van der Meulen
Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides. Diagnostics (Basel, Switzerland) 11 (10) (2021)
C Favaretto, Z Talip, F Borgna, P V Grundler, G Dellepiane, A Sommerhalder, H Zhang, R Schibli, S Braccini, C Müller, Nicholas P van der Meulen
Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging. EJNMMI radiopharmacy and chemistry 6 (1) (2021)
Nicholas P van der Meulen, Klaus Strobel, Thiago Viana Miranda Lima
New Radionuclides and Technological Advances in SPECT and PET Scanners. Cancers 13 (24) (2021)
Peter Bernhardt, Johanna Svensson, Jens Hemmingsson, Nicholas P van der Meulen, Jan Rijn Zeevaart, Mark W Konijnenberg, Cristina Müller, Jon Kindblom
Dosimetric Analysis of the Short-Ranged Particle Emitter 161Tb for Radionuclide Therapy of Metastatic Prostate Cancer. Cancers 13 (9) (2021)
Francesca Borgna, Patrick Barritt, Pascal V Grundler, Zeynep Talip, Susan Cohrs, Jan Rijn Zeevaart, Ulli Koester, Roger Schibli, Nicholas P van der Meulen, Cristina Müller
Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging. Pharmaceutics 13 (4) (2021)
Nicholas P van der Meulen, Roger Hasler, Zeynep Talip, Pascal V Grundler, Chiara Favaretto, Christoph A Umbricht, Cristina Müller, Gaia Dellepiane, Tommaso S Carzaniga, Saverio Braccini
Developments toward the Implementation of 44Sc Production at a Medical Cyclotron. Molecules (Basel, Switzerland) 25 (20) (2020)
Nicholas P van der Meulen, Roger Hasler, Alain Blanc, Renata Farkas, Martina Benešová, Zeynep Talip, Cristina Müller, Roger Schibli
Implementation of a new separation method to produce qualitatively improved 64 Cu. Journal of labelled compounds & radiopharmaceuticals 62 (8) (2020)
Zeynep Talip, Chiara Favaretto, Susanne Geistlich, Nicholas P van der Meulen
A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga, 44Sc, 177Lu and 161Tb. Molecules (Basel, Switzerland) 25 (4) (2020)
Nadezda Gracheva, Cristina Müller, Zeynep Talip, Stephan Heinitz, Ulli Köster, Jan Rijn Zeevaart, Alexander Vögele, Roger Schibli, Nicholas P van der Meulen
Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy. EJNMMI radiopharmacy and chemistry 4 (1) (2019)
Klaudia Siwowska, Patrycja Guzik, Katharina A Domnanich, Josep Maria Monné Rodríguez, Peter Bernhardt, Bernard Ponsard, Roger Hasler, Francesca Borgna, Roger Schibli, Ulli Koester, Nicholas P van der Meulen, Cristina Müller
Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations. Pharmaceutics 11 (8) (2019)
Renata Mikolajczak, Nicholas P van der Meulen, Suzanne E Lapi
Radiometals for imaging and theranostics, current production, and future perspectives. Journal of labelled compounds & radiopharmaceuticals 62 (10) (2019)
Cristina Müller, Maria De Prado Leal, Marco D Dominietto, Christoph A Umbricht, Sairos Safai, Rosalind L Perrin, Martina Egloff, Peter Bernhardt, Nicholas P van der Meulen, Damien C Weber, Roger Schibli, Antony J Lomax
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. Pharmaceutics 11 (9) (2019)

Nicholas P van der Meulen.css-eqlu8i{font-size:small;padding-left:4px;} (Nicholas P Van der Meulen, N P van der Meulen)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas P van der Meulen (Nicholas P Van der Meulen, N P van der Meulen)